SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 95 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $11,545,000 | +19.0% | 1,030,748 | +16.9% | 0.01% | +7.7% |
Q2 2017 | $9,701,000 | +15.2% | 881,896 | +2.7% | 0.01% | +18.2% |
Q1 2017 | $8,419,000 | -6.8% | 859,048 | +2.7% | 0.01% | -8.3% |
Q4 2016 | $9,037,000 | +0.3% | 836,809 | -4.8% | 0.01% | -14.3% |
Q3 2016 | $9,008,000 | +23.0% | 878,867 | +56.7% | 0.01% | +7.7% |
Q2 2016 | $7,326,000 | -5.1% | 560,973 | -20.1% | 0.01% | -7.1% |
Q1 2016 | $7,721,000 | -4.3% | 701,876 | -20.0% | 0.01% | 0.0% |
Q4 2015 | $8,069,000 | +50.8% | 877,076 | +13.7% | 0.01% | +27.3% |
Q3 2015 | $5,351,000 | -2.5% | 771,086 | +38.0% | 0.01% | 0.0% |
Q2 2015 | $5,488,000 | +192.1% | 558,851 | +163.5% | 0.01% | +175.0% |
Q1 2015 | $1,879,000 | +391.9% | 212,109 | +386.5% | 0.00% | +300.0% |
Q4 2014 | $382,000 | +297.9% | 43,600 | +213.7% | 0.00% | – |
Q3 2014 | $96,000 | -37.7% | 13,900 | -52.5% | 0.00% | – |
Q2 2014 | $154,000 | -68.3% | 29,280 | -72.6% | 0.00% | -100.0% |
Q1 2014 | $486,000 | -57.7% | 106,880 | -53.1% | 0.00% | -66.7% |
Q4 2013 | $1,149,000 | -37.8% | 227,980 | -37.4% | 0.00% | -57.1% |
Q3 2013 | $1,847,000 | -52.0% | 364,380 | -53.0% | 0.01% | -50.0% |
Q2 2013 | $3,846,000 | +67.6% | 775,400 | +45.6% | 0.01% | +40.0% |
Q4 2012 | $2,295,000 | – | 532,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|